In Vitro Antibacterial Activity of a New Cephalosporin, FR295389, against IMP-type Metallo-β-lactamase-producers

スポンサーリンク

概要

• 論文の詳細を見る
• 2008-01-25

著者

• Hatano Kazuo

  Pharmacology Research Labs Astellas Pharma Inc.

• IKEDA Fumiaki

  Pharmacology Research Laboratories, Astellas Pharma, Inc.

• Ikeda Fumiaki

  Pharmacology Research Labs Astellas Pharma Inc.

• TAKEDA Shinobu

  Pharmacology Research Labs, Astellas Pharma Inc.

• Takeda Shinobu

  Pharmacology Research Labs Astellas Pharma Inc.

• IKEDA Fumiaki

  Pharmacology Research Laboratories Astellas Pharma Inc.

関連論文

• Direct Comparison of the Pharmacodynamics of Four Antifungal Drugs in a Mouse Model of Disseminated Candidiasis Using Microbiological Assays of Serum Drug Concentrations
• Determination of Antifungal Activities in Serum Samples from Mice Treated with Different Antifungal Drugs Allows Detection of an Active Metabolite of Itraconazole
• In Vitro Antibacterial Activity of a New Cephalosporin, FR295389, against IMP-type Metallo-β-lactamase-producers
• Use of a serum-based antifungal susceptibility assay to predict the in vivo efficacy of novel echinocandin compounds

スポンサーリンク